» Articles » PMID: 29610560

Early Diagnosis of Type 2 Diabetes Based on Multiple Biomarkers and Non-invasive Indices

Overview
Specialty Biochemistry
Date 2018 Apr 4
PMID 29610560
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

We previously reported that type 2 diabetes risk, early impaired glucose tolerance and insulin resistance can be predicted by measuring the fasting levels of certain biomarkers. Here we validated these findings in randomly recruited healthy volunteers ( = 101) based on biomarker expression as well as various non-invasive indices. Weight, body mass index, waist circumference and visceral fat differed between individuals with impaired fasting glucose and/or impaired glucose tolerance, and normal subjects. Fasting plasma levels of glycated hemoglobin, leptin, pro-insulin and retinol binding protein 4 differed between impaired fasting glucose/impaired glucose tolerance and normal subjects group and between newly detected diabetes and normal subjects group. Insulin resistance was correlated with fasting levels of insulin and leptin/adiponectin ( = 0.913); of insulin, retinol binding protein 4 and leptin/adiponectin ( = 0.903); and of insulin, glycated albumin, and leptin/adiponectin ( = 0.913). Type 2 diabetes risk, early impaired glucose tolerance and insulin resistance were predicted with >98% specificity and sensitivity by comparing fasting glucose levels to the estimated Matsuda Index based on fasting levels of insulin, adiponectin and leptin with or without oxidative lineolate metabolites. Non-invasive indices are slightly correlated with glucose tolerance and insulin resistance but do not increase the accuracy of predicting type 2 diabetes risk.

Citing Articles

Significance of Singlet Oxygen Molecule in Pathologies.

Murotomi K, Umeno A, Shichiri M, Tanito M, Yoshida Y Int J Mol Sci. 2023; 24(3).

PMID: 36769060 PMC: 9917472. DOI: 10.3390/ijms24032739.


Colorimetric and Electrochemical Screening for Early Detection of Diabetes Mellitus and Diabetic Retinopathy-Application of Sensor Arrays and Machine Learning.

Faura G, Boix-Lemonche G, Holmeide A, Verkauskiene R, Volke V, Sokolovska J Sensors (Basel). 2022; 22(3).

PMID: 35161465 PMC: 8839630. DOI: 10.3390/s22030718.


Review of methods for detecting glycemic disorders.

Bergman M, Abdul-Ghani M, DeFronzo R, Manco M, Sesti G, Fiorentino T Diabetes Res Clin Pract. 2020; 165:108233.

PMID: 32497744 PMC: 7977482. DOI: 10.1016/j.diabres.2020.108233.


Utility of hemoglobin A1c in detecting risk of type 2 diabetes: comparison of hemoglobin A1c with other biomarkers.

Umeno A, Yoshida Y J Clin Biochem Nutr. 2019; 65(1):59-64.

PMID: 31379415 PMC: 6667390. DOI: 10.3164/jcbn.19-16.


Comprehensive measurements of hydroxylinoleate and hydroxyarachidonate isomers in blood samples from primary open-angle glaucoma patients and controls.

Umeno A, Tanito M, Kaidzu S, Takai Y, Horie M, Yoshida Y Sci Rep. 2019; 9(1):2171.

PMID: 30778084 PMC: 6379359. DOI: 10.1038/s41598-018-36952-6.

References
1.
Badwey J, Karnovsky M . Active oxygen species and the functions of phagocytic leukocytes. Annu Rev Biochem. 1980; 49:695-726. DOI: 10.1146/annurev.bi.49.070180.003403. View

2.
Fukui T, Yamauchi K, Maruyama M, Yasuda T, Kohno M, Abe Y . Significance of measuring oxidative stress in lifestyle-related diseases from the viewpoint of correlation between d-ROMs and BAP in Japanese subjects. Hypertens Res. 2011; 34(9):1041-5. DOI: 10.1038/hr.2011.76. View

3.
Flehmig G, Scholz M, Kloting N, Fasshauer M, Tonjes A, Stumvoll M . Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation. PLoS One. 2014; 9(6):e99785. PMC: 4072672. DOI: 10.1371/journal.pone.0099785. View

4.
Yoshida Y, Umeno A, Shichiri M . Lipid peroxidation biomarkers for evaluating oxidative stress and assessing antioxidant capacity in vivo. J Clin Biochem Nutr. 2013; 52(1):9-16. PMC: 3541426. DOI: 10.3164/jcbn.12-112. View

5.
Matsuda M, DeFronzo R . Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999; 22(9):1462-70. DOI: 10.2337/diacare.22.9.1462. View